Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Ajanta Pharma Limited (NSE: AJANTPHARM), ISIN INE031B01049 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AJANTPHARM last traded at ₹3347.90 (+0.29%), with a 52-week range of ₹2445.80 to ₹3796.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 63.47%, FIIs 7.62%, DIIs 21.94%, mutual funds 17.95%.
EquiSense Score (ECS): 84/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.